Literature DB >> 8327461

Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles.

G Pfitzer1, C Zeugner, M Troschka, J M Chalovich.   

Abstract

Caldesmon is known to inhibit actin-activated myosin ATPase activity in solution, to inhibit force production when added to skeletal muscle fibers, and to alter actin movement in the in vitro cell motility assay. It is less clear that caldesmon can inhibit contraction in smooth muscle cells in which caldesmon is abundant. We now show that caldesmon and its 20-kDa actin-binding fragment are able to inhibit force in chemically skinned gizzard fiber bundles, which are activated by a constitutively active myosin light-chain kinase in the presence and absence of okadaic acid. This inhibitory effect is reversed by high concentrations of Ca2+ and calmodulin. Therefore, caldesmon may act by increasing the level of myosin phosphorylation required to obtain full activation. Our results also suggest that caldesmon does not act to maintain force in smooth muscle by cross-linking myosin with actin since competition of binding of caldesmon with myosin does not cause a reduction in tension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327461      PMCID: PMC46835          DOI: 10.1073/pnas.90.13.5904

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Isolation of the native form of chicken gizzard myosin light-chain kinase.

Authors:  P K Ngai; C A Carruthers; M P Walsh
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

2.  Ca2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-Sepharose affinity chromatography.

Authors:  R Gopalakrishna; W B Anderson
Journal:  Biochem Biophys Res Commun       Date:  1982-01-29       Impact factor: 3.575

3.  Structure and action of heteronemertine polypeptide toxins: disulfide bonds of Cerebratulus lacteus toxin B-IV.

Authors:  K M Blumenthal; W R Kem
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

4.  Caldesmon150 regulates the tropomyosin-enhanced actin-myosin interaction in gizzard smooth muscle.

Authors:  K Sobue; K Takahashi; I Wakabayashi
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

5.  Smooth muscle caldesmon. Rapid purification and F-actin cross-linking properties.

Authors:  A Bretscher
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

6.  Caldesmon-induced inhibition of ATPase activity of actomyosin and contraction of skinned fibres of chicken gizzard smooth muscle.

Authors:  A Szpacenko; J Wagner; R Dabrowska; J C Rüegg
Journal:  FEBS Lett       Date:  1985-11-11       Impact factor: 4.124

7.  Change of Ca2+ requirement for myosin phosphorylation by prostaglandin F2 alpha.

Authors:  E Suematsu; M Resnick; K G Morgan
Journal:  Am J Physiol       Date:  1991-08

8.  Inhibition of smooth muscle actin-activated myosin Mg2+-ATPase activity by caldesmon.

Authors:  P K Ngai; M P Walsh
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

9.  Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin.

Authors:  K Sobue; Y Muramoto; M Fujita; S Kakiuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Caldesmon is an elongated, flexible molecule localized in the actomyosin domains of smooth muscle.

Authors:  D O Fürst; R A Cross; J De Mey; J V Small
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  18 in total

1.  Mutant Caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis.

Authors:  S Yamashiro; H Chern; Y Yamakita; F Matsumura
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

2.  The effects of caldesmon extraction on mechanical properties of skinned smooth muscle fibre preparations.

Authors:  U Malmqvist; A Arner; R Makuch; R Dabrowska
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

3.  Affinity and structure of complexes of tropomyosin and caldesmon domains.

Authors:  E J Hnath; C L Wang; P A Huber; S B Marston; G N Phillips
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

4.  Inhibition of cross-bridge binding to actin by caldesmon fragments in skinned skeletal muscle fibers.

Authors:  J F Heubach; R Hartwell; M Ledwon; T Kraft; B Brenner; J M Chalovich
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

5.  Thiophosphorylation-induced Ca(2+) sensitization of guinea-pig ileum contractility is not mediated by Rho-associated kinase.

Authors:  G Pfitzer; D Sonntag-Bensch; D Brkic-Koric
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

6.  Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins.

Authors:  C Lucius; A Arner; A Steusloff; M Troschka; F Hofmann; K Aktories; G Pfitzer
Journal:  J Physiol       Date:  1998-01-01       Impact factor: 5.182

7.  Kinetics of binding of caldesmon to actin.

Authors:  J M Chalovich; Y D Chen; R Dudek; H Luo
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

8.  Characterization of a caldesmon fragment that competes with myosin-ATP binding to actin.

Authors:  L Velaz; Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

9.  Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle.

Authors:  G F Nixon; K Iizuka; C M Haystead; T A Haystead; A P Somlyo; A V Somlyo
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

10.  Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1.

Authors:  A Wirth; M Schroeter; C Kock-Hauser; E Manser; J M Chalovich; P De Lanerolle; G Pfitzer
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.